Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-06-18 Sale |
2021-06-22 7:52 pm |
PLIANT THERAPEUTICS INC. | PLRX | Lefebvre Eric Chief Medical Officer |
12,500 | $28.87 | $360,821 | 137,080 (Direct) |
View |
| 2021-06-14 Sale |
2021-06-15 8:03 pm |
PLIANT THERAPEUTICS INC. | PLRX | Coulie Bernard President and CEO |
4,000 | $33.03 | $132,102 | 504,157 (Indirect Direct) |
View |
| 2021-05-14 Sale |
2021-05-17 7:34 pm |
PLIANT THERAPEUTICS INC. | PLRX | Coulie Bernard President and CEO |
3,500 | $28.64 | $100,224 | 508,157 (Indirect Direct) |
View |
| 2021-04-14 Sale |
2021-04-15 8:05 pm |
PLIANT THERAPEUTICS INC. | PLRX | Coulie Bernard President and CEO |
3,500 | $30.33 | $106,161 | 849,037 (Indirect Direct) |
View |
| 2021-03-18 Sale |
2021-03-19 7:09 pm |
PLIANT THERAPEUTICS INC. | PLRX | Lefebvre Eric Chief Medical Officer |
12,500 | $39.41 | $492,678 | 149,580 (Direct) |
View |
| 2021-03-15 Sale |
2021-03-17 7:36 pm |
PLIANT THERAPEUTICS INC. | PLRX | Coulie Bernard President and CEO |
3,500 | $38.52 | $134,835 | 509,157 (Indirect Direct) |
View |
| 2021-02-16 Sale |
2021-02-17 7:00 pm |
PLIANT THERAPEUTICS INC. | PLRX | Coulie Bernard President and CEO |
3,500 | $32.67 | $114,352 | 512,657 (Indirect Direct) |
View |
| 2021-01-14 Sale |
2021-01-15 7:00 pm |
PLIANT THERAPEUTICS INC. | PLRX | Coulie Bernard President and CEO |
3,500 | $26.38 | $92,325 | 516,157 (Indirect Direct) |
View |
| 2020-12-18 Sale |
2020-12-21 8:00 pm |
PLIANT THERAPEUTICS INC. | PLRX | Lefebvre Eric Chief Medical Officer |
12,500 | $26.54 | $331,752 | 162,080 (Direct) |
View |
| 2020-12-14 Sale |
2020-12-16 8:00 pm |
PLIANT THERAPEUTICS INC. | PLRX | Coulie Bernard President and CEO |
3,500 | $27.37 | $95,790 | 519,657 (Indirect Direct) |
View |
| 2020-12-01 Sale |
2020-12-02 8:00 pm |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
18,734 | $30 | $562,035 | 253,416 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-01-26 Option Award |
2022-02-02 8:15 pm |
N/A 2032-01-25 |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
124,000 | $0 | 124,000 (Direct) |
View |
| 2022-01-26 Option Award |
2022-02-02 8:14 pm |
N/A 2032-01-25 |
PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer |
112,500 | $0 | 112,500 (Direct) |
View |
| 2022-01-26 Option Award |
2022-02-02 8:13 pm |
N/A 2032-01-25 |
PLIANT THERAPEUTICS INC. | PLRX | Lefebvre Eric Chief Medical Officer |
140,000 | $0 | 140,000 (Direct) |
View |
| 2022-01-26 Option Award |
2022-02-02 8:12 pm |
N/A 2032-01-25 |
PLIANT THERAPEUTICS INC. | PLRX | Coulie Bernard President and CEO |
440,000 | $0 | 440,000 (Direct) |
View |
| 2021-09-03 Exercise |
2021-09-03 6:27 pm |
N/A N/A |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
20,000 | $2.08 | 217,718 (Direct) |
View |
| 2021-09-03 Exercise |
2021-09-03 6:27 pm |
N/A 2029-01-23 |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
20,000 | $0 | 217,718 (Direct) |
View |
| 2021-06-29 Option Award(A) |
2021-07-01 8:14 pm |
N/A 2031-06-28 |
PLIANT THERAPEUTICS INC. | PLRX | PYOTT DAVID E I Director |
13,286 | $0 | 13,286 (Direct) |
View |
| 2021-06-29 Option Award |
2021-06-30 8:54 pm |
N/A 2031-06-28 |
PLIANT THERAPEUTICS INC. | PLRX | Shah Smital Director |
13,286 | $0 | 13,286 (Direct) |
View |
| 2021-06-29 Option Award |
2021-06-30 8:49 pm |
N/A 2021-06-28 |
PLIANT THERAPEUTICS INC. | PLRX | PYOTT DAVID E I Director |
13,286 | $0 | 13,286 (Direct) |
View |
| 2021-06-29 Option Award |
2021-06-30 8:47 pm |
N/A 2031-06-28 |
PLIANT THERAPEUTICS INC. | PLRX | Huh Hoyoung Director |
13,286 | $0 | 13,286 (Direct) |
View |
| 2021-06-29 Option Award |
2021-06-30 8:37 pm |
N/A 2031-06-28 |
PLIANT THERAPEUTICS INC. | PLRX | HOMCY CHARLES J Director |
13,286 | $0 | 13,286 (Direct) |
View |
| 2021-06-29 Option Award |
2021-06-30 8:30 pm |
N/A 2031-06-28 |
PLIANT THERAPEUTICS INC. | PLRX | Exter Neil Director |
13,286 | $0 | 13,286 (Direct) |
View |
| 2021-06-29 Option Award |
2021-06-30 8:24 pm |
N/A 2031-06-28 |
PLIANT THERAPEUTICS INC. | PLRX | Curnutte John T Director |
13,286 | $0 | 13,286 (Direct) |
View |
| 2021-06-29 Option Award |
2021-06-30 8:10 pm |
N/A 2031-06-28 |
PLIANT THERAPEUTICS INC. | PLRX | CROWELL GAYLE A Director |
13,286 | $0 | 13,286 (Direct) |
View |
| 2021-06-29 Option Award |
2021-06-30 7:50 pm |
N/A 2031-06-28 |
PLIANT THERAPEUTICS INC. | PLRX | Bruhn Suzanne Louise Director |
13,286 | $0 | 13,286 (Direct) |
View |
| 2021-05-26 Exercise |
2021-05-28 7:58 pm |
N/A N/A |
PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer |
4,500 | $2.08 | 170,016 (Direct) |
View |
| 2021-05-26 Exercise |
2021-05-28 7:58 pm |
N/A 2029-01-23 |
PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer |
4,500 | $0 | 170,016 (Direct) |
View |
| 2021-04-13 Exercise |
2021-04-15 8:05 pm |
N/A N/A |
PLIANT THERAPEUTICS INC. | PLRX | Coulie Bernard President and CEO |
6,000 | $2.08 | 849,037 (Direct) |
View |
| 2021-04-13 Exercise |
2021-04-15 8:05 pm |
N/A 2029-01-23 |
PLIANT THERAPEUTICS INC. | PLRX | Coulie Bernard President and CEO |
6,000 | $0 | 849,037 (Direct) |
View |
| 2021-03-05 Exercise |
2021-03-05 8:51 pm |
N/A N/A |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
20,000 | $2.08 | 217,718 (Direct) |
View |
| 2021-03-05 Exercise |
2021-03-05 8:51 pm |
N/A 2029-01-23 |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
20,000 | $0 | 217,718 (Direct) |
View |
| 2021-01-23 Option Award |
2021-01-26 8:00 pm |
N/A 2031-01-22 |
PLIANT THERAPEUTICS INC. | PLRX | Howes Barbara Chief Human Resource Officer |
42,500 | $0 | 42,500 (Direct) |
View |
| 2021-01-23 Option Award |
2021-01-26 8:00 pm |
N/A 2031-01-22 |
PLIANT THERAPEUTICS INC. | PLRX | Coulie Bernard President and CEO |
250,000 | $0 | 250,000 (Direct) |
View |
| 2021-01-23 Option Award |
2021-01-26 8:00 pm |
N/A 2031-01-22 |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
74,250 | $0 | 74,250 (Direct) |
View |
| 2021-01-23 Option Award |
2021-01-26 8:00 pm |
N/A 2031-01-22 |
PLIANT THERAPEUTICS INC. | PLRX | Lefebvre Eric Chief Medical Officer |
73,250 | $0 | 73,250 (Direct) |
View |
| 2021-01-23 Option Award |
2021-01-26 8:00 pm |
N/A 2031-01-22 |
PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer |
62,250 | $0 | 62,250 (Direct) |
View |
| 2021-01-23 Option Award |
2021-01-26 8:00 pm |
N/A 2031-01-22 |
PLIANT THERAPEUTICS INC. | PLRX | Ouimette Mike General Counsel & Corp. Sec'y |
15,520 | $0 | 15,520 (Direct) |
View |
| 2021-01-12 Option Award |
2021-01-13 6:15 pm |
N/A 2031-01-11 |
PLIANT THERAPEUTICS INC. | PLRX | PYOTT DAVID E I Director |
26,573 | $0 | 26,573 (Direct) |
View |
| 2020-12-30 Exercise |
2021-01-04 8:00 pm |
N/A N/A |
PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer |
3,500 | $2.08 | 170,016 (Direct) |
View |
| 2020-12-30 Exercise |
2021-01-04 8:00 pm |
N/A 2029-01-23 |
PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer |
3,500 | $0 | 170,016 (Direct) |
View |
| 2020-12-21 Exercise |
2020-12-23 8:00 pm |
N/A N/A |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
4,500 | $2.08 | 217,718 (Direct) |
View |
| 2020-12-21 Exercise |
2020-12-23 8:00 pm |
N/A 2029-01-23 |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
4,500 | $0 | 217,718 (Direct) |
View |
| 2020-12-01 Exercise |
2020-12-02 8:00 pm |
N/A N/A |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
11,591 | $2.08 | 253,416 (Direct) |
View |
| 2020-12-01 Exercise |
2020-12-02 8:00 pm |
N/A 2029-01-23 |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
18,734 | $0 | 253,416 (Direct) |
View |
| 2020-12-01 Exercise |
2020-12-02 8:00 pm |
N/A N/A |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
7,143 | $6.22 | 253,416 (Direct) |
View |
| 2020-10-09 Option Award |
2020-10-13 8:00 pm |
N/A 2030-10-08 |
PLIANT THERAPEUTICS INC. | PLRX | Ouimette Mike General Counsel |
108,240 | $0 | 108,240 (Direct) |
View |
| 2020-06-05 Conversion |
2020-06-09 9:24 pm |
N/A N/A |
PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer |
72,541 | $0 | 246,711 (Direct) |
View |
| 2020-02-28 Option Award |
2020-06-09 9:24 pm |
N/A N/A |
PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer |
27,322 | $13.08 | 246,711 (Indirect) |
View |
| 2020-03-31 Option Award |
2020-06-09 9:24 pm |
N/A 2030-03-30 |
PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer |
70,352 | $0 | 246,711 (Direct) |
View |